Evidence map›Paper›PMID 32666422›Full record

ArticleJournal of neurovirology2020

Ageusia and anosmia, a common sign of COVID-19? A case series from four countries.

Jair Vargas-Gandica, Daniel Winter, Rainer Schnippe, Andrea G Rodriguez-Morales, Johana Mondragon, Juan Pablo Escalera-Antezana, María Del Pilar Trelles-Thorne, D Katterine Bonilla-Aldana, Alfonso J Rodriguez-Morales, Alberto Paniz-Mondolfi

Abstract readCase Reports
In one paragraph

Article in Journal of neurovirology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Effects of nasal inflammation on the olfactory bulb.Journal of neuroinflammation · 2022
    Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. SARS-CoV-2 andNarra J · 2021
    Article
  17. Article
  18. Review
  19. Coronavirus 2019 Infectious Disease Epidemic: Where We Are, What Can Be Done and Hope For.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2021
    Article
  20. Seroprevalence of SARS-CoV-2 antibody among healthcare workers in a university hospital in Mallorca, Spain, during the first wave of the COVID-19 pandemic.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jair Vargas-GandicaKlinik für Allgemeine Innere Medizin, Sankt Vinzenz Hospital, Rheda-Wiedenbrück, Germany.
Daniel WinterKlinik für Allgemeine Innere Medizin, Sankt Vinzenz Hospital, Rheda-Wiedenbrück, Germany.
Rainer SchnippeKlinik für Allgemeine Innere Medizin, Sankt Vinzenz Hospital, Rheda-Wiedenbrück, Germany.
Andrea G Rodriguez-MoralesLatin American Network of Coronavirus Disease 2019-COVID-19 Research (LANCOVID-19), Pereira, Risaralda, Colombia.
Johana MondragonLatin American Network of Coronavirus Disease 2019-COVID-19 Research (LANCOVID-19), Pereira, Risaralda, Colombia.
Juan Pablo Escalera-AntezanaLatin American Network of Coronavirus Disease 2019-COVID-19 Research (LANCOVID-19), Pereira, Risaralda, Colombia.
María Del Pilar Trelles-ThorneIcahn School of Medicine at Mount Sinai, New York, NY, USA.
D Katterine Bonilla-AldanaLatin American Network of Coronavirus Disease 2019-COVID-19 Research (LANCOVID-19), Pereira, Risaralda, Colombia.
Alfonso J Rodriguez-MoralesLatin American Network of Coronavirus Disease 2019-COVID-19 Research (LANCOVID-19), Pereira, Risaralda, Colombia. arodriguezm@utp.edu.co.ORCID 0000-0001-9773-2192
Alberto Paniz-MondolfiLatin American Network of Coronavirus Disease 2019-COVID-19 Research (LANCOVID-19), Pereira, Risaralda, Colombia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over the course of the pandemic due to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), multiple new clinical manifestations, as the consequence of the tropism of the virus, have been recognized. That includes now the neurological manifestations and conditions, such as headache, encephalitis, as well as olfactory and taste disorders. We present a series of ten cases of RT-PCR-confirmed SARS-CoV-2-infected patients diagnosed with viral-associated olfactory and taste loss from four different countries.

Indexed as

AdultAgedAged, 80 and overAgeusiaBetacoronavirusBrainBrain DiseasesCoronavirus InfectionsCOVID-19EuropeFemaleHeadacheHumansMaleMiddle AgedNorth AmericaAgeusiaAnosmiaClinical manifestationsCOVID-19NeurologicalSARS-CoV-2

Identifiers

PMID32666422
PMCPMC7359421

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.